Crinetics Pharmaceuticals, Inc. ($CRNX)
Schilke Tobin โ Chief Financial Officer
Shares
6,713
Price
$39.67
Total Value
$266,304.71
Nearby Earnings
Feb 26, 2026
EPS:Est: -1.40
Revenue:Est: $4.74M
Transaction Details
| Insider | Schilke Tobin |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 3, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 4, 2026 |
| Shares Sold | 6,713 |
| Price per Share | $39.67 |
| Total Value | $266,304.71 |
| Shares Owned After | 78,121 |
| Derivative | No |
| Accession Number | 0001628280-26-014772 |
| Document | View SEC Filing |